We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
- Authors
Akay, Catherine L; Meric-Bernstam, Funda; Hunt, Kelly K; Grubbs, Elizabeth G; Bedrosian, Isabelle; Tucker, Susan L; Kuerer, Henry M; Hoffman, Karen E; Babiera, Gildy V; Strom, Eric A; Buchholz, Thomas A; Mittendorf, Elizabeth A
- Abstract
We previously developed a prognostic index for assessing local-regional recurrence (LRR) risk in patients undergoing breast conservation therapy (BCT) after neoadjuvant chemotherapy. The prognostic index assigns a point for each of the following variables: clinical N2/N3 disease, lymphovascular invasion, residual pathologic tumor size >2 cm, and multifocal residual disease on pathology. The current study was undertaken to evaluate this prognostic index in an independent cohort.
- Publication
Annals of surgical oncology, 2012, Vol 19, Issue 3, p901
- ISSN
1534-4681
- Publication type
Journal Article
- DOI
10.1245/s10434-011-2006-7